BlackRock, Inc. 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-23 8:57 pm Sale |
2025-03-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
2,179,420 5.700% |
-1,703,129 (-43.87%) |
Filing |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
3,882,549 10.600% |
0 (Unchanged) |
Filing |
| 2024-10-21 4:11 pm Sale |
2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
3,882,549 10.600% |
-379,196 (-8.90%) |
Filing |
| 2024-01-23 4:13 pm Sale |
2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
4,261,745 11.900% |
-217,676 (-4.86%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
4,479,421 12.600% |
0 (Unchanged) |
Filing |
| 2023-01-20 5:17 pm Purchase |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
4,479,421 12.600% |
758,184 (+20.37%) |
Filing |
| 2022-07-08 4:56 pm Purchase |
2022-06-30 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
3,721,237 10.500% |
3,721,237 (New Position) |
Filing |